320
Participants
Start Date
September 14, 2022
Primary Completion Date
March 10, 2023
Study Completion Date
February 28, 2024
AdCLD-CoV19-1 OMI (Part A)
20 participants will receive investigational product (AdCLD-CoV19-1 OMI) via intramuscular injection in the deltoid muscle
AdCLD-CoV19-1 OMI (Part B)
250 participants will receive investigational product (AdCLD-CoV19-1 OMI) via intramuscular injection in the deltoid muscle
Placebo (Part B)
50 participants will receive placebo via intramuscular injection in the deltoid muscle
Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do
Korea University Ansan Hospital, Gyeonggi-do
The Catholic University of Korea ST. Vincent's Hospital, Gyeonggi-do
Gachon University Gil Medical Center, Incheon
Inha University Hospital, Incheon
Hallym University Kangnam Sacred Heart Hospital, Seoul
Korea University Guro Hospital, Seoul
Cellid Co., Ltd.
INDUSTRY